Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Study sponsor: Arcus Biosciences, Inc. · RCUS
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2030-11-30Estimated
Enrollment · participants610Estimated
Source updated2026-11-02Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.